Skip to main content

Table 6 Summary of interim survey respondents affiliated trial subject areas

From: Identifying trial recruitment uncertainties using a James Lind Alliance Priority Setting Partnership – the PRioRiTy (Prioritising Recruitment in Randomised Trials) study

Trial subject area

Number

Percentage

Oncology/haematology – cancer

161

21

Neurology – neurodegenerative diseases, vascular diseases

77

10

Cardiology – cardiovascular disease

62

8

Orthopaedics/musculoskeletal

56

7

Mental health

51

7

Metabolism – diabetes mellitus

47

6

Vaccines – preventive vaccines

45

6

Reproductive health

33

4

Critical care

24

3

Infectious diseases

21

3

Gastroenterology – hepatology, nephrology

18

2

Surgery

16

2

Respiratory

15

2

Paediatrics/neonates

13

2

Inflammatory conditions (e.g. osteoarthritis, rheumatoid arthritis, fibromyalgia)

11

1

Ophthalmology

9

1

Involved in multiple trials

34

4

Other

82

11

Totala

785

96

  1. aData missing in 30 respondents